Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

This study has been completed.
Information provided by (Responsible Party):
Bionor Immuno AS Identifier:
First received: April 14, 2008
Last updated: January 27, 2015
Last verified: August 2010